John A. Orwin - 09 Nov 2023 Form 3 Insider Report for CARGO Therapeutics, Inc. (CRGX)

Role
Director
Signature
/s/ Halley Gilbert, as attorney-in-fact for John A. Orwin
Issuer symbol
CRGX
Transactions as of
09 Nov 2023
Transactions value $
$0
Form type
3
Filing time
09 Nov 2023, 17:02:51 UTC
Previous filing
18 Sep 2023
Next filing
15 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRGX Stock Option (Right to Buy) 09 Nov 2023 Common Stock 15.9K $1.09 Direct F1, F2
holding CRGX Stock Option (Right to Buy) 09 Nov 2023 Common Stock 63.8K $5.03 Direct F1, F3
holding CRGX Stock Option (Right to Buy) 09 Nov 2023 Common Stock 20.3K $5.03 Direct F1, F5
holding CRGX Stock Option (Right to Buy) 09 Nov 2023 Common Stock 37.8K $5.03 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a 1-for-13.5685 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement on November 3, 2023.
F2 1/48th of the shares subject to the option vest on the last day of each calendar month measured from September 2, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F3 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 9, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F4 1/48th of the shares subject to the option vest on each monthly anniversary measured from July 7, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F5 1/48th of the shares subject to the option vest on each monthly anniversary measured from October 27, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Remarks:

Exhibit 24.1 - Power of Attorney